People with liver disease, kidney issues, or certain allergies should consult a doctor before use
There is no conclusive long-term human data, so its recommended to use BPC-157 under the guidance of a healthcare provider
No claims are made regarding medical, therapeutic, or clinical outcomes
Track symptoms and get AI-powered recommendations for dose adjustments
GHK-Cu works differently
Read review Dihexa for Endometriosis Brain Fog The November 2025 Lancet O&G/WH 'overlooked symptom' commentary from Edinburgh EXPPECT, the April 2025 Horn FACT-Cog 1,239-patient survey (~80% perceived cognitive impairment), the March 2025 NICE TA1057 Ryeqo approval (first daily pill on NHS), the April 2024 NICE NG73 update, the April 2026 renewed Womens Health Strategy with 117 action points, the 2023 Greaves CNS-wide glial activation mouse model, the BDNF/TrkB central-sensitisation directionality paradox, and the ~1.5 million UK women affected